With Nature stating that almost 60% of clinical professionals expect eConsent adoption to continue post-pandemic, it is clear the benefits behind a digitally-enabled consent process have garnered trust. But a recent Medable poll found that the informed consent process still remains rooted in paper. This reliance on paper comes at a cost though: low enrollment, poor patient retention and issues around site compliance leading to inspection findings and costly trial delays.
In this on-demand webinar, you will learn:
.png)
